Literature DB >> 13651577

Some effects of reserpine and hydraliazine upon tissue respiration and the concentration of adenosine nucleotides in certain tissues.

S M KIRPEKAR, J J LEWIS.   

Abstract

The effects of reserpine and hydrallazine upon the oxygen uptake of preparations of rat brain, liver, and kidney and rabbit aorta have been investigated using the Warburg "Direct" method. In these tissues reserpine did not significantly stimulate respiration at any of the doses used. Concentrations of 10 or 50 mug./ml. had no significant effect upon respiration, but higher doses (330 mug./ml.) depressed it in all the tissues studied. This effect was also seen in rat brain at a reserpine concentration of 100 mug./ml. which had no significant effect in other tissues. Hydrallazine (50 or 100 mug./ml.) depressed respiration in all tissues studied. Stimulation at lower doses was not seen.After sublethal doses of reserpine, depletion of energy rich phosphate compounds occurred in brain and liver but not in skeletal muscle and heart. Hydrallazine also depleted brain of energy rich phosphate compounds, but did not affect liver, heart, or skeletal muscle. The bearing of these results on the mode of action of reserpine and hydrallazine is discussed.

Entities:  

Keywords:  HYDRALAZINE/effects; METABOLISM, TISSUE/effect of drugs on; NUCLEOSIDES AND NUCLEOTIDES/metabolism; RESERPINE/effects

Mesh:

Substances:

Year:  1959        PMID: 13651577      PMCID: PMC1481821          DOI: 10.1111/j.1476-5381.1959.tb00926.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  9 in total

1.  The chemical constitution and biochemical effects of psychotherapeutic and structurally related agents.

Authors:  L G ABOOD; L ROMANCHEK
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

2.  Inhibition of biologic acetylation by 1-hydrazinophthalazine.

Authors:  C D DOUGLASS; C J DILLAHA; J DILLAHA; S L KOUNTZ
Journal:  J Lab Clin Med       Date:  1957-04

3.  Pharmacological properties of hydrallazine, dihydrallazine and some related compounds.

Authors:  S M KIRPEKAR; J J LEWIS
Journal:  J Pharm Pharmacol       Date:  1957-12       Impact factor: 3.765

4.  Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat.

Authors:  M HOLZBAUER; M VOGT
Journal:  J Neurochem       Date:  1956-05       Impact factor: 5.372

5.  Release of adenosine triphosphate along with adrenaline and noradrenaline following stimulation of the adrenal medulla.

Authors:  A CARLSSON; N A HILLARP
Journal:  Acta Physiol Scand       Date:  1956-09-26

6.  The uncoupling of oxidative phosphorylation as a mechanism of drug action.

Authors:  T M BRODY
Journal:  Pharmacol Rev       Date:  1955-09       Impact factor: 25.468

7.  The effect of 3:5-dinitroortho-cresol on phosphocreatine and the adenosine phosphate compounds of rat tissues.

Authors:  V H PARKER
Journal:  Biochem J       Date:  1954-07       Impact factor: 3.857

8.  Serotonin release as a possible mechanism of reserpine action.

Authors:  A PLETSCHER; P A SHORE; B B BRODIE
Journal:  Science       Date:  1955-08-26       Impact factor: 47.728

9.  Metabolic and other effects of reserpine upon smooth and skeletal muscle.

Authors:  C N GILLIS; J J LEWIS
Journal:  Br J Pharmacol Chemother       Date:  1957-12
  9 in total
  1 in total

1.  [Reserpine in experimental thyreotoxicosis: its action on the adenosine nucleotide of heart tissues].

Authors:  E MASCITELLI-CORIANDOLI
Journal:  Experientia       Date:  1960-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.